CRISPR-based genome editing in primary human pancreatic islet cells
The editing of primary human islets could provide insight into diabetes pathogenesis. Here the authors use CRISPR-Cas9 to target regulatory elements associated with T2D susceptibility.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/22d2b0339efc4aa29c30bb51db113c85 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|